Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1965 Nov 20;2(5472):1215–1219. doi: 10.1136/bmj.2.5472.1215

Plasma renin concentration in human hypertension . II. Renin in relation to aetiology.

J J Brown, D L Davies, A F Lever, J I Robertson
PMCID: PMC1846624  PMID: 5849134

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONS W. L., NUSIMOVICH B., VANDERLINDE R. J., THORN G. W. Effect of exogenous adrenocortical hormones and states of adrenal dysfunction on body sodium and potassium composition. J Clin Endocrinol Metab. 1958 Jun;18(6):611–628. doi: 10.1210/jcem-18-6-611. [DOI] [PubMed] [Google Scholar]
  2. BAGSHAWE K. D., CURTIS J. R., GARNETT E. S. EFFECT OF PROLONGED HYDROCORTISONE ADMINISTRATION ON POTASSIUM METABOLISM. Lancet. 1965 Jan 2;1(7375):18–21. doi: 10.1016/s0140-6736(65)90923-2. [DOI] [PubMed] [Google Scholar]
  3. BARTTER F. C., BIGLIERI E. G. Primary aldosteronism: clinical staff conference at the National Institutes of Health. Ann Intern Med. 1958 Mar;48(3):647–654. doi: 10.7326/0003-4819-48-3-647. [DOI] [PubMed] [Google Scholar]
  4. BERNATZ P. E., HUNT J. C., HARRISON E. G., Jr Idiopathic fibrous and fibromuscular stenoses of the renal artery. A frequent obstacle to revascularization in renal vascular hypertension. Arch Surg. 1962 Oct;85:608–616. doi: 10.1001/archsurg.1962.01310040080010. [DOI] [PubMed] [Google Scholar]
  5. BIRON P., CHRETIEN M., KOIW E., GENEST J. Effects of angiotensin infusions on aldosterone and electrolyte excretion in normal subjects and patients with hypertension and adrenocortical disorders. Br Med J. 1962 Jun 9;1(5292):1569–1575. doi: 10.1136/bmj.1.5292.1569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BLACKWELL B., MARLEY E., TAYLOR D. EFFECTS OF YEAST EXTRACT AFTER MONOAMINE-OXIDASE INHIBITION. Lancet. 1965 May 29;1(7396):1166–1166. doi: 10.1016/s0140-6736(65)91994-x. [DOI] [PubMed] [Google Scholar]
  7. BOUCHER R., VEYRAT R., DE CHAMPLAIN J., GENEST J. NEW PROCEDURES FOR MEASUREMENT OF HUMAN PLASMA ANGIOTENSIN AND RENIN ACTIVITY LEVELS. Can Med Assoc J. 1964 Jan 25;90:194–201. [PMC free article] [PubMed] [Google Scholar]
  8. BRANDT P. W., DACIE J. V., STEINER R. E., SZUR L. INCIDENCE OF RENAL LESIONS IN POLYCYTHAEMIA: A SURVEY OF 91 PATIENTS. Br Med J. 1963 Aug 24;2(5355):468–472. doi: 10.1136/bmj.2.5355.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BROWN J. J., DAVIES D. L., DOAK P. B., LEVER A. F., ROBERTSON J. I. PLASMA-RENIN IN NORMALPREGNANCY. Lancet. 1963 Nov 2;2(7314):900–901. doi: 10.1016/s0140-6736(63)90614-7. [DOI] [PubMed] [Google Scholar]
  10. BROWN J. J., DAVIES D. L., LEVER A. F., PEART W. S., ROBERTSON J. I. PLASMA RENIN IN A CASE OF CONN'S SYNDROME WITH FIBRINOID LESIONS: USE OF SPINONOLACTONE IN TREATMENT. Br Med J. 1964 Dec 26;2(5425):1636–1637. doi: 10.1136/bmj.2.5425.1636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brown J. J., Davies D. L., Lever A. F., Robertson J. I., Tree M. The estimation of renin in human plasma. Biochem J. 1964 Dec;93(3):594–600. doi: 10.1042/bj0930594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DOORENBOS H., ELINGS H. S., VAN BUCHEM F. S. Primary aldosteronism due to adrenocortical hyperplasia. Lancet. 1956 Aug 18;271(6938):335–337. doi: 10.1016/s0140-6736(56)92194-8. [DOI] [PubMed] [Google Scholar]
  13. GOWENLOCK A. H., WRONG O. Hyperaldosteronism secondary to renal ischaemia. Q J Med. 1962 Jul;31:323–343. [PubMed] [Google Scholar]
  14. GWINUP G., GANTT C. L., HAMWI G. J. THE PRODUCTION OF HYPOKALEMIC ALKALOSIS WITH HYDROCORTISONE IN SUBJECTS WITH ADRENAL INSUFFICIENCY. Metabolism. 1964 Sep;13:831–836. doi: 10.1016/0026-0495(64)90050-2. [DOI] [PubMed] [Google Scholar]
  15. HANSEN P. DEMONSTRATION OF ERYTHROPOIETIN IN URINE AND IN KIDNEY EXTRACTS FROM RABBITS WITH EXPERIMENTAL CONSTRICTION OF THE LEFT RENAL ARTERY. Acta Pathol Microbiol Scand. 1964;61:514–520. doi: 10.1111/apm.1964.61.4.514. [DOI] [PubMed] [Google Scholar]
  16. HELMER O. M., JUDSON W. E. The quantitative determination of renin in the plasma of patients with arterial hypertension. Circulation. 1963 Jun;27:1050–1060. doi: 10.1161/01.cir.27.6.1050. [DOI] [PubMed] [Google Scholar]
  17. HIRASHIMA K., TAKAKU F. Experimental studies on erythropoietin. II. The relationship between juxtaglomerular cells and erythropoietin. Blood. 1962 Jul;20:1–8. [PubMed] [Google Scholar]
  18. JONES N. F., BARRACLOUGH M. A., CLAPHAM W. F. RENAL HYPERTENSION AND POLYCYTHAEMIA. Br Med J. 1965 Feb 13;1(5432):448–448. doi: 10.1136/bmj.1.5432.448-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. KIRKENDALL W. M., FITZ A., ARMSTRONG M. L. HYPOKALEMIA AND THE DIAGNOSIS OF HYPERTENSION. Dis Chest. 1964 Apr;45:337–344. doi: 10.1378/chest.45.4.337. [DOI] [PubMed] [Google Scholar]
  20. LUKE R. G., KENNEDY A. C., STIRLING W. B., MCDONALD G. A. RENAL ARTERY STENOSIS, HYPERTENSION , AND POLYCYTHAEMIA. Br Med J. 1965 Jan 16;1(5428):164–166. doi: 10.1136/bmj.1.5428.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. MADER I. J., ISERI L. T. Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid. Am J Med. 1955 Dec;19(6):976–988. doi: 10.1016/0002-9343(55)90164-9. [DOI] [PubMed] [Google Scholar]
  22. MILLS J. N., THOMAS S., WILLIAMSON K. S. The acute effect of hydrocortisone, deoxycorticosterone and aldosterone upon the excretion of sodium, potassium and acid by the human kidney. J Physiol. 1960 May;151:312–331. doi: 10.1113/jphysiol.1960.sp006440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MILNE M. D., MUEHRCKE R. C., AIRD I. Primary aldosteronism. Q J Med. 1957 Jul;26(103):317–333. [PubMed] [Google Scholar]
  24. MITUS W. J., TOYAMA K. EXPERIMENTAL RENAL ERYTHROCYTOSIS; ROLE OF THE JUXTAGLOMERULAR APPARATUS. Arch Pathol. 1964 Dec;78:658–664. [PubMed] [Google Scholar]
  25. MOORE F. D., EDELMAN I. S., OLNEY J. M., JAMES A. H., BROOKS L., WILSON G. M. Body sodium and potassium. III. Interrelated trends in alimentary, renal and cardiovascular disease; lack of correlation between body stores and plasma concentration. Metabolism. 1954 Jul;3(4):334–350. [PubMed] [Google Scholar]
  26. MORRIS R. E., Jr, ROBINSON P. R., SCHEELE G. A. THE RELATIONSHIP OF ANGIOTENSIN TO RENAL HYPERTENSION. Can Med Assoc J. 1964 Jan 25;90:272–276. [PMC free article] [PubMed] [Google Scholar]
  27. REEVES G., LOWENSTEIN L., SOMMERS S. C. A suggested mechanism of erythropoietic control by juxtaglomerular cells. Am J Med Sci. 1963 Feb;245:184–188. [PubMed] [Google Scholar]
  28. ROSS E. J. EFFECT OF PROLONGED HYDROCORTISONE ADMINISTRATION ON POTASSIUM METABOLISM. Lancet. 1965 Jan 23;1(7378):215–215. doi: 10.1016/s0140-6736(65)91000-7. [DOI] [PubMed] [Google Scholar]
  29. SMITH H. Pre-azotaemic renal anaemia: a clinical hypothesis supported by animal experiment. Br J Urol. 1963 Mar;35:33–40. doi: 10.1111/j.1464-410x.1963.tb02591.x. [DOI] [PubMed] [Google Scholar]
  30. SUTTON D., BRUNTON F. J., FOOT E. C., GUTHRIE J. FIBROMUSCULAR, FIBROUS AND NON-ATHEROMATOUS RENAL ARTERY STENOSIS AND HYPERTENSION. Clin Radiol. 1963 Oct;14:381–391. doi: 10.1016/s0009-9260(63)80025-2. [DOI] [PubMed] [Google Scholar]
  31. TASHIMA C. K. EFFECT OF PROLONGED HYDROCORTISONE ADMINISTRATION ON POTASSIUM METABOLISM. Lancet. 1965 Apr 17;1(7390):866–866. doi: 10.1016/s0140-6736(65)91400-5. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES